Mordechai Yigla
- Pulmonary and Respiratory Medicine top 1%
- Cardiology and Cardiovascular Medicine top 5%
- Epidemiology top 5%
- Physiology top 5%
- Surgery top 10%
- Co-authors
- Shimon A. ReisnerFarid NakhoulOren FruchterZaid AbassiNaveh TovEmília HardakAnna SolomonovAlexandra Balbir‐Gurman
- Topics
- Pulmonary Hypertension Research and Treatments (16 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers)Asthma and respiratory diseases (10 papers)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Mordechai Yigla
69 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 109
- Pulmonary and Respiratory Medicine 1.5k
- Cardiology and Cardiovascular Medicine 562
- Epidemiology 477
- Physiology 387
- Surgery 308
Countries citing papers authored by Mordechai Yigla
This map shows the geographic impact of Mordechai Yigla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mordechai Yigla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mordechai Yigla more than expected).
Fields of papers citing papers by Mordechai Yigla
This network shows the impact of papers produced by Mordechai Yigla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mordechai Yigla. The network helps show where Mordechai Yigla may publish in the future.
Co-authorship network of co-authors of Mordechai Yigla
This figure shows the co-authorship network connecting the top 25 collaborators of Mordechai Yigla. A scholar is included among the top collaborators of Mordechai Yigla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mordechai Yigla. Mordechai Yigla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 48 | |
| 3 | 22 | |
| 4 | 13 | |
| 5 | 50 | |
| 6 | 5 | |
| 7 | 4 | |
| 8 | 105 | |
| 9 | 9 | |
| 10 | 9 | |
| 11 | 5 | |
| 12 | 84 | |
| 13 | 78 | |
| 14 | 52 | |
| 15 | 46 | |
| 16 | 10 | |
| 17 | Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group. | 15 |
| 18 | 11 | |
| 19 | 29 | |
| 20 | 1 |
About Mordechai Yigla
Mordechai Yigla is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Genetics, having authored 71 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Asthma and respiratory diseases (10 papers). The work is most often cited by research in Microbiology (54 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Genetics (268 citations). Mordechai Yigla has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Shimon A. Reisner, Farid Nakhoul, Oren Fruchter, Zaid Abassi, Naveh Tov, Emília Hardak, Anna Solomonov, Alexandra Balbir‐Gurman, Ilana Oren and Yolanda Braun‐Moscovici. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Kidney International and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.